SITAPRIME 25

SITAPRIME 25 — Sitagliptin 25 mg Tablets

Overview

SITAPRIME 25 is an oral antidiabetic medication containing Sitagliptin 25 mg, a Dipeptidyl Peptidase-4 (DPP-4) inhibitor designed to manage type 2 diabetes mellitus.

By enhancing incretin hormone activity, Sitagliptin improves insulin secretion after meals and suppresses glucagon release, helping to maintain stable blood glucose levels throughout the day.

SITAPRIME 25 is ideal for patients needing mild glycemic control, particularly those on low-dose therapy or requiring titration in combination with other antidiabetic agents.

---

Composition

Each tablet contains:

• Sitagliptin 25 mg – DPP-4 inhibitor that enhances insulin secretion and reduces glucagon, regulating blood sugar effectively.

---

Dosage Form

• Tablet

---

Therapeutic Class

• Oral Antidiabetic / DPP-4 Inhibitor

---

Indications

SITAPRIME 25 Tablets are indicated for:

• Type 2 diabetes mellitus in adults

• Patients inadequately controlled with diet and exercise alone

• Use as monotherapy or in combination with other antidiabetic medications such as Metformin or Sulfonylureas

• Managing postprandial hyperglycemia

---

Mechanism of Action

• Sitagliptin inhibits the DPP-4 enzyme, prolonging the activity of incretin hormones (GLP-1 and GIP).

• This results in increased insulin secretion after meals and reduced glucagon levels, improving both postprandial and fasting blood glucose control.

---

Dosage and Administration

• Recommended Dose: 25 mg once daily, with or without food, or as prescribed by the physician

• Route: Oral

• Duration: As per medical guidance, depending on glycemic control and patient response

Note: Regular monitoring of blood glucose levels is recommended during therapy.

---

Benefits

• Controls fasting and postprandial blood sugar levels

• Improves glycemic control in type 2 diabetes

• Can be used as low-dose monotherapy or combination therapy

• Low risk of hypoglycemia when used alone

• Supports better metabolic balance and reduced risk of diabetes complications

---

Side Effects

SITAPRIME 25 is generally well tolerated. Possible side effects may include:

• Mild gastrointestinal disturbances

• Headache

• Upper respiratory tract infections

• Rare hypoglycemia when combined with other antidiabetic drugs

Patients should consult their physician if side effects persist.

---

Precautions

• Not suitable for type 1 diabetes mellitus or diabetic ketoacidosis

• Use with caution in renal impairment; dose adjustment may be required

• Monitor for pancreatitis symptoms (abdominal pain, nausea, vomiting)

• Inform your doctor about other medications to avoid interactions

• Consult a physician before use during pregnancy or lactation

---

Storage

Store below 25°C, in a dry place away from sunlight. Keep out of reach of children.

---

Key Product Information

• Brand Name: SITAPRIME 25

• Composition: Sitagliptin 25 mg

• Dosage Form: Tablet

• Therapeutic Class: Oral Antidiabetic / DPP-4 Inhibitor

• Manufacturer: [Insert Company Name]

• Packaging: [Example: 10×10 Tablets / Strip]

---

Why Choose SITAPRIME 25

• Effective low-dose DPP-4 inhibitor therapy for type 2 diabetes

• Helps maintain stable blood sugar levels

• Suitable for titration or combination therapy

• Convenient once-daily dosing

• Manufactured under GMP-certified quality standards

---

Conclusion

SITAPRIME 25 (Sitagliptin 25 mg Tablets) offers effective glycemic control for patients requiring mild to moderate management of type 2 diabetes. Its once-daily dosing and low risk of hypoglycemia make it a safe and convenient choice for maintaining healthy postprandial and fasting blood sugar levels.